Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fujibayashi

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Nuclear Medicine and Biology|November 14, 1997
Reassessment of FDG uptake in tumor cells: high FDG uptake as a reflection of oxygen-independent glycolysis dominant energy productionA Waki, Y Fujibayashi, Y Yonekura, et al.
Biological & Pharmaceutical Bulletin|February 1, 1993
Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imagingY Fujibayashi, K Wada, H Taniuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgGT Furukawa, Y Fujibayashi, M Fukunaga, et al.
Annals of Nuclear Medicine|March 1, 1990
Problems of [S-methyl-11C]-L-methionine as a protein synthesis marker in the pancreasY Fujibayashi, K Kawai, Y Yonekura, et al.
Nuclear Medicine and Biology|August 12, 2000
The development of (99m)Tc-analog of Cu-DTS as an agent for imaging hypoxiaK Horiuchi, T Tsukamoto, M Saito, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 1, 1996
[Basic studies on the 111In labeled antisense oligonucleotide for tumor imaging]Y Fujibayashi, K Nakagawa, A Waki, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Monoiodo-D-tyrosine, an artificial amino acid radiopharmaceutical for selective measurement of membrane amino acid transport in the pancreasK Kawai, Y Fujibayashi, H Saji, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1990
62Cu-labeling of human serum albumin-dithiosemicarbazone (HSA-DTS) conjugate for regional plasma volume measurement: application of new 62Zn/62Cu generator systemY Fujibayashi, K Matsumoto, Y Arano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1997
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potentialY Fujibayashi, H Taniuchi, Y Yonekura, et al.
Annals of Nuclear Medicine|February 1, 1995
Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imagingY Fujibayashi, H Taniuchi, K Wada, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Nuclear Medicine and Biology|November 14, 1997
Reassessment of FDG uptake in tumor cells: high FDG uptake as a reflection of oxygen-independent glycolysis dominant energy productionA Waki, Y Fujibayashi, Y Yonekura, et al.
Biological & Pharmaceutical Bulletin|February 1, 1993
Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imagingY Fujibayashi, K Wada, H Taniuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgGT Furukawa, Y Fujibayashi, M Fukunaga, et al.
Annals of Nuclear Medicine|March 1, 1990
Problems of [S-methyl-11C]-L-methionine as a protein synthesis marker in the pancreasY Fujibayashi, K Kawai, Y Yonekura, et al.
Nuclear Medicine and Biology|August 12, 2000
The development of (99m)Tc-analog of Cu-DTS as an agent for imaging hypoxiaK Horiuchi, T Tsukamoto, M Saito, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 1, 1996
[Basic studies on the 111In labeled antisense oligonucleotide for tumor imaging]Y Fujibayashi, K Nakagawa, A Waki, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Monoiodo-D-tyrosine, an artificial amino acid radiopharmaceutical for selective measurement of membrane amino acid transport in the pancreasK Kawai, Y Fujibayashi, H Saji, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1990
62Cu-labeling of human serum albumin-dithiosemicarbazone (HSA-DTS) conjugate for regional plasma volume measurement: application of new 62Zn/62Cu generator systemY Fujibayashi, K Matsumoto, Y Arano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1997
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potentialY Fujibayashi, H Taniuchi, Y Yonekura, et al.
Annals of Nuclear Medicine|February 1, 1995
Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imagingY Fujibayashi, H Taniuchi, K Wada, et al.
Pageof 12